Silibinin plus Stupp protocol as conversion therapy for unresectable glioblastoma with pSTAT3 expression, an oasis in the desert? A case report description.

Ostrom, 2022, CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019, Neuro-oncol., 24, v1, 10.1093/neuonc/noac202 Stupp, 2009, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, Lancet. Oncol., 10, 459, 10.1016/S1470-2045(09)70025-7 Hervey-Jumper, 2016, Maximizing safe resection of low- and high-grade glioma, J. Neuro-Oncol., 130, 269, 10.1007/s11060-016-2110-4 Sanai, 2011, An extent of resection threshold for newly diagnosed glioblastomas, J. Neurosurg., 115, 3, 10.3171/2011.2.JNS10998 Signorelli, 2010, Review of current microsurgical management of insular gliomas, Acta Neurochir., 152, 19, 10.1007/s00701-009-0450-y Murrone, 2019, Insular gliomas: a surgical reappraisal based on a systematic review of the literature, J. Neurosurg. Sci., 63, 566, 10.23736/S0390-5616.17.04045-0 Jacobo, 2021, The role of neoadjuvant therapy to improve the extent of resection in "unresectable" gliomas, W. Neurosurg., 146, 53, 10.1016/j.wneu.2020.10.109 Kaloshi, 2015, Letter to the Editor: neoadjuvant chemotherapy to maximize glioblastoma resection in the elderly, J. Neurosurg., 123, 295, 10.3171/2012.7.JNS12342 Tabouret, 2021, TEMOBIC: phase II trial of neoadjuvant chemotherapy for unresectable anaplastic gliomas: an ANOCEF study, The Oncol., 26, 647, 10.1002/onco.13765 Poli, 2015, STAT3-mediated metabolic reprograming in cellular transformation and implications for drug resistance, Front. Oncol., 5, 121, 10.3389/fonc.2015.00121 Yu, 2014, Revisiting STAT3 signalling in cancer: new and unexpected biological functions, Nat. Rev. Canc., 14, 736, 10.1038/nrc3818 Zhao, 2016, Feedback activation of STAT3 as a cancer drug-resistance mechanism, Trends Pharm. Sci., 37, 47, 10.1016/j.tips.2015.10.001 Kohsaka, 2012, STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression, Mol. Canc. Ther., 11, 1289, 10.1158/1535-7163.MCT-11-0801 Loguercio, 2011, Silybin and the liver: from basic research to clinical practice, W. J. Gastroent., 17, 2288, 10.3748/wjg.v17.i18.2288 Picart, 2017, Is fluorescence-guided surgery with 5-ala in eloquent areas for malignant gliomas a reasonable and useful technique?, N-Ch, 63, 189